Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELLING
2.6 TREATMENT TYPE LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 AVERAGE SELLING PRICE (ASP) ANALYSIS
4.4 MICRO AND MACRO ECONOMIC FACTORS
4.5 KEY PRICING STRATEGIES
4.6 HEALTHCARE ECONOMY
4.7 PENETRATION AND GROWTH PROSPECT MAPPING
4.8 TECHNOLOGY ROADMAP
4.9 VALUE CHAIN ANALYSIS
5 COMPANY-WISE OVERVIEW OF INTRA-ARTICULAR HYALURONIC ACID (HA) INJECTION PRODUCTS BASED ON MOLECULAR WEIGHT -
6 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, REGULATORY FRAMEWORK
6.1 NORTH AMERICA
6.2 EUROPE
6.3 ASIA-PACIFIC
6.4 MIDDLE EAST AND AFRICA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF KNEE OSTEOARTHRITIS
7.1.2 GROWING PREFERENCE FOR MINIMALLY INVASIVE AND NON-SURGICAL TREATMENT OPTIONS
7.1.3 CLINICAL VALIDATION OF HYALURONIC ACID IN OSTEOARTHRITIS TREATMENT
7.1.4 RECENT LAUNCHES OF HYALURONIC ACID FOR OSTEOARTHRITIS TREATMENT
7.2 RESTRAINTS
7.2.1 COMPETITION OF ALTERNATIVE THERAPIES FOR KNEE OSTEOARTHRITIS
7.2.2 REGULATORY CHALLENGES FACED BY THE MANUFACTURERS IN THE HYALURONIC ACID MARKET
7.3 OPPORTUNITIES
7.3.1 ADVANCEMENTS IN HYALURONIC ACID FORMULATIONS AND DELIVERY SYSTEMS
7.3.2 RAISING AWARENESS AND ACCEPTANCE OF HYALURONIC ACID FOR KNEE OSTEOARTHRITIS TREATMENT AMONG PHYSICIANS AND PATIENTS
7.3.3 THE IMPACT OF COMBINING HYALURONIC ACID WITH OTHER THERAPEUTIC OPTIONS FOR KNEE OSTEOARTHRITIS
7.4 CHALLENGES
7.4.1 COST-RELATED CHALLENGES AND ACCESSIBILITY CONCERNS FOR HYALURONIC ACID THERAPY IN KNEE OSTEOARTHRITIS
7.4.2 SHORT-TERM BENEFITS WITH LIMITED LASTING EFFICACY OF HYALURONIC ACID FOR KNEE OA
8 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SINGLE INJECTION (MONOPHASIC)
8.3 THREE-INJECTION REGIMEN (TRIPHASIC)
8.4 FIVE-INJECTION REGIMEN (PENTAPHASIC)
9 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION
9.1 OVERVIEW
9.2 CROSS-LINKED HYALURONIC ACID
9.3 NON-CROSS-LINKED HYALURONIC ACID
10 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT
10.1 OVERVIEW
10.2 HIGH MOLECULAR WEIGHT (HMW) HA
10.3 LOW MOLECULAR WEIGHT (LMW) HA
10.4 INTERMEDIATE MOLECULAR WEIGHT HA
11 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS
11.1 OVERVIEW
11.2 VISCOSUPPLEMENTATION
11.3 ANTI-INFLAMMATORY & PAIN REDUCTION
11.4 CARTILAGE PROTECTION & REGENERATION
12 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 ORTHOPEDIC CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 SPECIALTY PAIN MANAGEMENT CENTERS
13 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL & ONLINE PHARMACIES
13.4 OTHERS
14 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION
14.1 ASIA-PACIFIC
14.1.1 CHINA
14.1.2 JAPAN
14.1.3 INDIA
14.1.4 SOUTH KOREA
14.1.5 AUSTRALIA
14.1.6 SINGAPORE
14.1.7 THAILAND
14.1.8 INDONESIA
14.1.9 MALAYSIA
14.1.10 TAIWAN
14.1.11 NEW ZEALAND
14.1.12 PHILIPPINES
14.1.13 VIETNAM
14.1.14 KAZAKHSTAN
14.1.15 BRUNEI
14.1.16 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 LG CHEM
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 BIOVENTUS
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 SEIKAGAKU CORPORATION
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 SANOFI
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 ANIKA THERAPEUTICS, INC.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 EUPRAXIA PHARMACEUTICALS
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 FIDIA FARMACEUTICI S.P.A.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 FERRING
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO.,LTD.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 HANMI PHARM.CO., LTD
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 IBSA INSTITUT BIOCHIMIQUE SA.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 TRB CHEMEDICA INTERNATIONAL SA
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 VIATRIS INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 VIRCHOW BIOTECH
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 ZIMMER BIOMET
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 COMPANY PRODUCT AND ADVANCEMENT IN FORMULATION
TABLE 2 COMPANY PRODUCT AND COMBINATION THERAPY
TABLE 3 PRICE OF THE HYALURONIC ACID INJECTION
TABLE 4 COMPANY PRODUCT AND LASTING EFFICACY
TABLE 5 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC SINGLE INJECTION (MONOPHASIC) IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC THREE-INJECTION REGIMEN (TRIPHASIC) IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC FIVE-INJECTION REGIMEN (PENTAPHASIC IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC CROSS-LINKED HYALURONIC ACID IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC NON-CROSS-LINKED HYALURONIC ACID IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC HIGH MOLECULAR WEIGHT (HMW) HA IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC LOW MOLECULAR WEIGHT (LMW) HA IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC INTERMEDIATE MOLECULAR WEIGHT HA IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC VISCOSUPPLEMENTATION IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC ANTI-INFLAMMATORY & PAIN REDUCTION IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC CARTILAGE PROTECTION & REGENERATION IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC HOSPITALS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC ORTHOPEDIC CLINICS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC SPECIALTY PAIN MANAGEMENT CENTERS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC DIRECT TENDER IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC RETAIL & ONLINE PHARMACIES IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC OTHERS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 36 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 37 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 38 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 39 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 40 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 41 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 42 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 43 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 44 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 45 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 46 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 47 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 48 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 49 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 50 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 51 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 52 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 53 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 54 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 55 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 56 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 57 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 58 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 59 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 60 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 62 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 63 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 64 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 65 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 66 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 68 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 69 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 70 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 71 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 72 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 74 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 75 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 76 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 77 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 78 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 80 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 81 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 82 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 83 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 84 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 86 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 87 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 88 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 89 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 90 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 91 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 92 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 93 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 94 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 95 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 96 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 98 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 99 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 100 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 101 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 102 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 104 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 105 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 106 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 107 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 108 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 110 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 111 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 112 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 113 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 114 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 115 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 116 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 117 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 118 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 119 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 120 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 122 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)
TABLE 123 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)
TABLE 124 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 125 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 126 REST OF ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
List of Figure
FIGURE 1 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: SEGMENTATION
FIGURE 2 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: LIFELINE CURVE
FIGURE 7 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: MARKET END USER COVERAGE GRID
FIGURE 10 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: SEGMENTATION
FIGURE 12 THREE SEGMENTS COMPRISE THE ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE
FIGURE 13 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT EXECUTIVE SUMMARY
FIGURE 14 STRATEGIC DECISIONS
FIGURE 15 RISING PREVALENCE OF KNEE OSTEOARTHRITIS IS EXPECTED TO DRIVE THE GROWTH OF ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT FROM 2025 TO 2032
FIGURE 16 THE SINGLE INJECTION (MONOPHASIC) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT IN 2025 - 2032
FIGURE 17 DROC ANALYSIS
FIGURE 18 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, 2024
FIGURE 19 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)
FIGURE 20 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 21 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, 2024
FIGURE 23 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, 2025-2032 (USD THOUSAND)
FIGURE 24 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, CAGR (2025-2032)
FIGURE 25 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, 2024
FIGURE 27 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, 2025-2032 (USD THOUSAND)
FIGURE 28 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, CAGR (2025-2032)
FIGURE 29 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, 2024
FIGURE 31 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, 2025-2032 (USD THOUSAND)
FIGURE 32 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, CAGR (2025-2032)
FIGURE 33 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, 2024
FIGURE 35 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 36 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, CAGR (2025-2032)
FIGURE 37 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, LIFELINE CURVE
FIGURE 38 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, 2024
FIGURE 39 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, 2025-2032 (USD THOUSAND)
FIGURE 40 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 41 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY SHARE 2024 (%)
